版本:
中国

BRIEF-Synthetic Biologics announces completion of enrollment for Phase 2b

Sept 20 Synthetic Biologics Inc :

* Announces completion of enrollment for Phase 2b Proof-Of-Concept clinical trial for SYN-004 (ribaxamase)

* Company anticipates announcing top-line results during Q1 of 2017. Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐